Back to Search Start Over

PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells.

Authors :
Stathopoulou C
Gangaplara A
Mallett G
Flomerfelt FA
Liniany LP
Knight D
Samsel LA
Berlinguer-Palmini R
Yim JJ
Felizardo TC
Eckhaus MA
Edgington-Mitchell L
Martinez-Fabregas J
Zhu J
Fowler DH
van Kasteren SI
Laurence A
Bogyo M
Watts C
Shevach EM
Amarnath S
Source :
Immunity [Immunity] 2018 Aug 21; Vol. 49 (2), pp. 247-263.e7. Date of Electronic Publication: 2018 Jul 24.
Publication Year :
2018

Abstract

CD4 <superscript>+</superscript> T cell differentiation into multiple T helper (Th) cell lineages is critical for optimal adaptive immune responses. This report identifies an intrinsic mechanism by which programmed death-1 receptor (PD-1) signaling imparted regulatory phenotype to Foxp3 <superscript>+</superscript> Th1 cells (denoted as Tbet <superscript>+</superscript> iTreg <subscript>PDL1</subscript> cells) and inducible regulatory T (iTreg) cells. Tbet <superscript>+</superscript> iTreg <subscript>PDL1</subscript> cells prevented inflammation in murine models of experimental colitis and experimental graft versus host disease (GvHD). Programmed death ligand-1 (PDL-1) binding to PD-1 imparted regulatory function to Tbet <superscript>+</superscript> iTreg <subscript>PDL1</subscript> cells and iTreg cells by specifically downregulating endo-lysosomal protease asparaginyl endopeptidase (AEP). AEP regulated Foxp3 stability and blocking AEP imparted regulatory function in Tbet <superscript>+</superscript> iTreg cells. Also, Aep <superscript>-/-</superscript> iTreg cells significantly inhibited GvHD and maintained Foxp3 expression. PD-1-mediated Foxp3 maintenance in Tbet <superscript>+</superscript> Th1 cells occurred both in tumor infiltrating lymphocytes (TILs) and during chronic viral infection. Collectively, this report has identified an intrinsic function for PD-1 in maintaining Foxp3 through proteolytic pathway.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-4180
Volume :
49
Issue :
2
Database :
MEDLINE
Journal :
Immunity
Publication Type :
Academic Journal
Accession number :
30054205
Full Text :
https://doi.org/10.1016/j.immuni.2018.05.006